First Trust Multi Cap Growth AlphaDEX Fund
FAD - ETF AI Analysis
Top Page
First Trust Multi Cap Growth AlphaDEX Fund (FAD)
FAD, the First Trust Multi Cap Growth AlphaDEX Fund, earns a solid overall rating thanks to several strong growth-focused holdings with healthy financial performance and positive business momentum. Key positions like Expedia and Expeditors International support the fund’s quality through robust earnings, strategic initiatives, and favorable technical trends, while names such as Guardant Health introduce some risk due to financial instability and valuation concerns. The main risk factor is the fund’s concentration in growth companies where high valuations and leverage in a few holdings could increase volatility and pressure the rating during market downturns.
FAD vs. SPDR S&P 500 ETF (SPY)
- AUM
- 588.54M
- Region
- North America
- Expense Ratio
- 0.63%
- Beta
- 1.09
- Issuer
- First Trust
- Inception Date
- May 08, 2007
- Dividend Yield
- 0.09%
- Asset Class
- Equity
- Index Tracked
- NASDAQ AlphaDEX Multi Cap Growth Index
FAD Summary
FAD, the First Trust Multi Cap Growth AlphaDEX Fund, is an ETF that follows the NASDAQ AlphaDEX Multi Cap Growth Index. It focuses on U.S. companies of all sizes that show strong growth potential, especially in technology and health care. Well-known holdings include Workday and Expedia, along with many other growing businesses across different sectors. Someone might invest in FAD to seek long-term growth while still spreading their money across many companies and industries. A key risk is that growth stocks can be more volatile, so the fund’s value can rise and fall sharply with changes in the market.
How much will it cost me?
This ETF has an expense ratio of 0.63%, which means you’ll pay about $6.30 per year for every $1,000 you invest. That’s higher than the average index ETF because it uses an actively managed, rules-based AlphaDEX strategy instead of simply tracking a basic market index.
What would affect this ETF?
FAD could benefit if the U.S. economy stays strong and innovation continues in technology and health care, since these sectors make up a large part of the fund and many top holdings are growth-focused companies that tend to do well when business spending and consumer demand are healthy. On the downside, rising interest rates, a slowdown in U.S. growth, or tighter regulations on tech and health care could hurt these companies, and the fund’s emphasis on growth stocks across all sizes may make it more sensitive to market downturns than more conservative, income-focused ETFs.
FAD Top 10 Holdings
FAD is leaning hard into U.S. growth stories, with a clear tilt toward tech and health care names that have been doing the heavy lifting. Okta, NetApp, and Pure Storage are rising on the back of AI and cloud momentum, giving the fund a strong tech engine. In health care, Illumina and Agilent are steadily adding to returns, even if valuation worries keep them from sprinting. On the softer side, Workday has been more mixed and Expedia is lagging, acting like a small anchor on an otherwise forward‑moving, U.S.-focused growth portfolio.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| SharkNinja, Inc. | 0.57% | $3.44M | $31.92B | 146.18% | 76Outperform | |
| Corpay Inc | 0.54% | $3.25M | $29.40B | 58.93% | 75Outperform | |
| Moderna | 0.47% | $2.82M | $101.49B | 841.65% | 59Neutral | |
| Newmont Mining | 0.47% | $2.80M | $124.66B | 31.71% | 81Outperform | |
| Medpace Holdings | 0.49% | $2.91M | $18.59B | 10.29% | 79Outperform | |
| Agilent | 0.47% | $2.80M | $50.15B | 18.42% | 73Outperform | |
| Workday | 0.46% | $2.74M | $45.52B | -15.78% | 73Outperform | |
| Expeditors International | 0.48% | $2.88M | $24.43B | 39.48% | 80Outperform | |
| Ross Stores | 0.47% | $2.82M | $76.33B | 48.26% | 80Outperform | |
| Westinghouse Air Brake Technologies | 0.48% | $2.89M | $50.93B | 46.28% | 79Outperform |
FAD Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FAD, the sentiment is Positive. The current price of 178.73 is above the 20-day moving average (MA) of 177.05, below the 50-day MA of 180.26, and below the 200-day MA of 178.99, indicating a neutral trend. The MACD of -1.59 indicates Negative momentum. The RSI at 51.01 is Neutral, neither overbought nor oversold. The STOCH value of 68.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FAD.
FAD Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $178.73 | $193.00(7.98% Upside) | $588.54M | 0.63% | 68Neutral | |
| $43.33 | $55.01(26.94% Upside) | $828.99M | 0.59% | 75Outperform | |
| $69.17 | $89.90(29.96% Upside) | $554.34M | 0.61% | 75Outperform | |
| $28.07 | $35.36(25.97% Upside) | $507.18M | 0.61% | 70Outperform | |
| $23.80 | $25.64(7.74% Upside) | $493.29M | 0.49% | 71Outperform | |
| $122.83 | $171.09(39.29% Upside) | $425.27M | 0.45% | 71Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 178.73 | 22.34 | 14.29% | |
| LSGR | Natixis Loomis Sayles Focused Growth ETF | 43.33 | -0.37 | -0.85% | |
| RJCA | RJ ClariVest Capital Appreciation ETF | 69.17 | -1.55 | -2.20% | |
| BASG | Brown Advisory Sustainable Growth ETF | 28.07 | 1.97 | 7.55% | |
| GQGU | GQG US Equity ETF | 23.80 | -0.76 | -3.09% | |
| FDG | American Century Focused Dynamic Growth ETF | 122.83 | 0.75 | 0.62% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
